Teresa De Marco, MD

InstitutionUniversity of California San Francisco
Address505 Parnassus Avenue
San Francisco CA 94143
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California IrvineM.D.1982School of Medicine
    Collapse Awards and Honors
    Castle Connolly2011Top Doctors
    UCSF Cardiovascular Research Institute2010Teresa De Marco, MD, Conference Room
    University of California, San Francisco2009R.H. and Jane G. Logan Endowed Chair in Cardiology
    University of California, San Francisco2008Honoree, 500th Thoracic Transplant Celebration
    San Francisco Magazine2005Best Cardiologists in the Bay Area
    University of California, San Francisco2004Exceptional Physician Award
    San Francisco Magazine2003Best Cardiologists in Bay Area
    2001  - 2011Best Doctors in America
    University of California, San Francisco2001Celebrated Faculty Women

    Collapse Overview 
    Collapse Overview
    CLINICAL INTERESTS: Advanced heart failure, cardiomyopathies, heart transplantation, mechanical circulatory support, and pulmonary hypertension
    RESEARCH INTERESTS: Translational research in the diagnosis, prognosis, medical and surgical treatment for the above disease states

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Inan OT, Baran Pouyan M, Javaid AQ, Dowling S, Etemadi M, Dorier A, Heller JA, Bicen AO, Roy S, De Marco T, Klein L. Novel Wearable Seismocardiography and Machine Learning Algorithms Can Assess Clinical Status of Heart Failure Patients. Circ Heart Fail. 2018 Jan; 11(1):e004313. PMID: 29330154.
      View in: PubMed
    2. Pittman S, Sethi P, Flavell RR, De Marco T, Hernandez Pampaloni M. Abnormal pulmonary 18F-florbetapir uptake in a patient evaluated for recurrent cardiac amyloidosis following orthotopic heart transplant. J Nucl Cardiol. 2017 Nov 03. PMID: 29101671.
      View in: PubMed
    3. Kallianos K, Brooks GC, Mukai K, Seguro de Carvalho F, Liu J, Naeger DM, De Marco T, Ordovas KG. Cardiac Magnetic Resonance Evaluation of Left Ventricular Myocardial Strain in Pulmonary Hypertension. Acad Radiol. 2018 Jan; 25(1):129-135. PMID: 28866441.
      View in: PubMed
    4. Psotka MA, McKee KY, Liu AY, Elia G, De Marco T. Palliative Care in Heart Failure: What Triggers Specialist Consultation? Prog Cardiovasc Dis. 2017 Sep - Oct; 60(2):215-225. PMID: 28483606.
      View in: PubMed
    5. Oudiz R, Agarwal M, Rischard F, De Marco T. An advanced protocol-driven transition from parenteral prostanoids to inhaled trepostinil in pulmonary arterial hypertension. Pulm Circ. 2016 Dec; 6(4):532-538. PMID: 28090295.
      View in: PubMed
    6. Gordon NA, O'Riordan DL, Dracup KA, De Marco T, Pantilat SZ. Let Us Talk About It: Heart Failure Patients' Preferences Toward Discussions about Prognosis, Advance Care Planning, and Spiritual Support. J Palliat Med. 2017 01; 20(1):79-83. PMID: 27603266.
      View in: PubMed
    7. Bertero T, Oldham WM, Cottrill KA, Pisano S, Vanderpool RR, Yu Q, Zhao J, Tai Y, Tang Y, Zhang YY, Rehman S, Sugahara M, Qi Z, Gorcsan J, Vargas SO, Saggar R, Saggar R, Wallace WD, Ross DJ, Haley KJ, Waxman AB, Parikh VN, De Marco T, Hsue PY, Morris A, Simon MA, Norris KA, Gaggioli C, Loscalzo J, Fessel J, Chan SY. Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension. J Clin Invest. 2016 Sep 01; 126(9):3313-35. PMID: 27548520; PMCID: PMC5004943 [Available on 12/01/16].
    8. Pantilat SZ, O'Riordan DL, Rathfon MA, Dracup KA, De Marco T. Etiology of Pain and Its Association with Quality of Life among Patients with Heart Failure. J Palliat Med. 2016 Dec; 19(12):1254-1259. PMID: 27494139.
      View in: PubMed
    9. Svetlichnaya J, Janmohammed M, De Marco T. Special Situations in Pulmonary Hypertension: Pregnancy and Right Ventricular Failure. Cardiol Clin. 2016 Aug; 34(3):473-87. PMID: 27443142.
      View in: PubMed
    10. Badhwar N, James J, Hoffmayer KS, O'Connell JW, Green D, De Marco T, Botvinick EH. Utility of Equilibrium Radionuclide Angiogram-Derived Measures of Dyssynchrony to Predict Outcomes in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy. J Nucl Med. 2016 Dec; 57(12):1880-1886. PMID: 27417646.
      View in: PubMed
    11. Barnett CF, De Marco T. Treatment of advanced group 2 PH. Prog Cardiovasc Dis. 2016 Jul-Aug; 59(1):78-86. PMID: 27417251.
      View in: PubMed
    12. Thomas RC, Singh A, Cowley P, Myagmar BE, Montgomery MD, Swigart PM, De Marco T, Baker AJ, Simpson PC. A Myocardial Slice Culture Model Reveals Alpha-1A-Adrenergic Receptor Signaling in the Human Heart. JACC Basic Transl Sci. 2016 Apr; 1(3):155-167. PMID: 27453955.
      View in: PubMed
    13. Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT, De Marco T, Escarce JJ, Evangelista LS, Hanna B, Ganiats TG, Greenberg BH, Greenfield S, Kaplan SH, Kimchi A, Liu H, Lombardo D, Mangione CM, Sadeghi B, Sadeghi B, Sarrafzadeh M, Tong K, Fonarow GC. Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition -- Heart Failure (BEAT-HF) Randomized Clinical Trial. JAMA Intern Med. 2016 Mar; 176(3):310-8. PMID: 26857383.
      View in: PubMed
    14. Parikh VN, Park J, Nikolic I, Channick R, Yu PB, De Marco T, Hsue PY, Chan SY. Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection. J Acquir Immune Defic Syndr. 2015 Nov 01; 70(3):236-41. PMID: 26473639; PMCID: PMC4610144 [Available on 11/01/16].
    15. Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiéry JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016 Mar 21; 37(12):942-54. PMID: 26508169; PMCID: PMC4800173.
    16. Klein L, Greenberg BH, Konstam MA, Gregory D, Kociol RD, Johnson MR, de Marco T. Activities and Compensation of Advanced Heart Failure Specialists: Results of the Heart Failure Society of America (HFSA) Survey. J Card Fail. 2015 Nov; 21(11):924-9. PMID: 26362520.
      View in: PubMed
    17. Johnson CJ, Roberts JD, James JH, Hoffmayer KS, Badhwar N, Ku IA, Zhao S, Naeger DM, Rao RK, O'Connell JW, De Marco T, Botvinick EH, Scheinman MM. Comparison of radionuclide angiographic synchrony analysis to echocardiography and magnetic resonance imaging for the diagnosis of arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2015 Jun; 12(6):1268-75. PMID: 25744613.
      View in: PubMed
    18. Howie-Esquivel J, Carroll M, Brinker E, Kao H, Pantilat S, Rago K, De Marco T. A Strategy to Reduce Heart Failure Readmissions and Inpatient Costs. Cardiol Res. 2015 Feb; 6(1):201-208. PMID: 28197226.
      View in: PubMed
    19. Naeger DM, Higgins C, De Marco T, Muzzarelli S, Ordovas KG. Low-intensity late gadolinium enhancement predominates in hypertrophic cardiomyopathy. Clin Imaging. 2015 May-Jun; 39(3):432-6. PMID: 25724224.
      View in: PubMed
    20. Deo RC, Musso G, Tasan M, Tang P, Poon A, Yuan C, Felix JF, Vasan RS, Beroukhim R, De Marco T, Kwok PY, MacRae CA, Roth FP. Prioritizing causal disease genes using unbiased genomic features. Genome Biol. 2014 Dec 03; 15(12):534. PMID: 25633252; PMCID: PMC4279789.
    21. Tampakakis E, Leary PJ, Selby VN, De Marco T, Cappola TP, Felker GM, Russell SD, Kasper EK, Tedford RJ. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail. 2015 Jan; 3(1):9-16. PMID: 25453535; PMCID: PMC4289416.
    22. Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W. [Pulmonary hypertension due to left heart diseases]. Turk Kardiyol Dern Ars. 2014 Oct; 42 Suppl 1:130-41. PMID: 25697040.
      View in: PubMed
    23. Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéy JL. [Pulmonary hypertension in chronic lung diseases]. Turk Kardiyol Dern Ars. 2014 Oct; 42 Suppl 1:142-52. PMID: 25697041.
      View in: PubMed
    24. Cogswell R, Pritzker M, De Marco T. Performance of the REVEAL pulmonary arterial hypertension prediction model using non-invasive and routinely measured parameters. J Heart Lung Transplant. 2014 Apr; 33(4):382-7. PMID: 24534251.
      View in: PubMed
    25. Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D100-8. PMID: 24355634.
      View in: PubMed
    26. Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D109-16. PMID: 24355635.
      View in: PubMed
    27. Cogswell R, McGlothlin D, Kobashigawa E, Shaw R, De Marco T. Performance of the REVEAL model in WHO Group 2 to 5 pulmonary hypertension: application beyond pulmonary arterial hypertension. J Heart Lung Transplant. 2013 Mar; 32(3):293-8. PMID: 23265906.
      View in: PubMed
    28. Cogswell R, Kobashigawa E, McGlothlin D, Shaw R, De Marco T. Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival. J Heart Lung Transplant. 2012 Nov; 31(11):1165-70. PMID: 23062726.
      View in: PubMed
    29. Roubinian N, Elliott CG, Barnett CF, Blanc PD, Chen J, De Marco T, Chen H. Effects of commercial air travel on patients with pulmonary hypertension air travel and pulmonary hypertension. Chest. 2012 Oct; 142(4):885-892. PMID: 22490871; PMCID: PMC3465107.
    30. Barnett CF, De Marco T. Pulmonary hypertension associated with left-sided heart disease. Heart Fail Clin. 2012 Jul; 8(3):447-59. PMID: 22748905.
      View in: PubMed
    31. Hong TT, Cogswell R, James CA, Kang G, Pullinger CR, Malloy MJ, Kane JP, Wojciak J, Calkins H, Scheinman MM, Tseng ZH, Ganz P, De Marco T, Judge DP, Shaw RM. Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2012 Jun; 9(6):961-7. PMID: 22300662; PMCID: PMC3349006.
    32. Barnett CF, De Marco T. A chocolate a day keeps the doctor away? J Physiol. 2011 Dec 15; 589(Pt 24):5921-2. PMID: 22174142; PMCID: PMC3286672.
    33. Weeks SG, Glantz SA, De Marco T, Rosen AB, Fleischmann KE. Secondhand smoke exposure and quality of life in patients with heart failure. Arch Intern Med. 2011 Nov 28; 171(21):1887-93. PMID: 22123794.
      View in: PubMed
    34. Koskenvuo JW, Mirsky R, Zhang Y, Helenius H, Angeli FS, De Marco T, Boyle AJ, Yeghiazarians Y. Evidence of diminished coronary flow in pulmonary hypertension: explaining angina pectoris in this patient group? Clin Physiol Funct Imaging. 2011 Nov; 31(6):477-84. PMID: 21981460.
      View in: PubMed
    35. Barnett CF, De Marco T. Can pulmonary arterial hypertension be diagnosed by an elevated pulmonary capillary wedge pressure outside of the guideline criteria? Chest. 2011 Sep; 140(3):828-829. PMID: 21896532.
      View in: PubMed
    36. Caleshu C, Sakhuja R, Nussbaum RL, Schiller NB, Ursell PC, Eng C, De Marco T, McGlothlin D, Burchard EG, Rame JE. Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy. Am J Med Genet A. 2011 Sep; 155A(9):2229-35. PMID: 21823217; PMCID: PMC3158811.
    37. Mirsky R, Jahn S, Koskenvuo JW, Sievers RE, Yim SM, Ritner C, Bernstein HS, Angeli FS, Boyle AJ, De Marco T, Yeghiazarians Y. Treatment of pulmonary arterial hypertension with circulating angiogenic cells. Am J Physiol Lung Cell Mol Physiol. 2011 Jul; 301(1):L12-9. PMID: 21398496.
      View in: PubMed
    38. McGlothlin D, De Marco T. Transplantation in adults with congenital heart disease. Prog Cardiovasc Dis. 2011 Jan-Feb; 53(4):312-23. PMID: 21295673.
      View in: PubMed
    39. Can pulmonary arterial hypertension be diagnosed by an elevated pulmonary capillary wedge pressure outside of the guideline criteria? Barnett CF, De Marco T. Chest. Can pulmonary arterial hypertension be diagnosed by an elevated pulmonary capillary wedge pressure outside of the guideline criteria?. 2011; 3(140):828-9.
    40. Koskenvuo JW, Mirsky R, Zhang Y, Angeli FS, Jahn S, Alastalo TP, Schiller NB, Boyle AJ, Chatterjee K, De Marco T, Yeghiazarians Y. A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model. Int J Cardiovasc Imaging. 2010 Jun; 26(5):509-18. PMID: 20140524; PMCID: PMC2868165.
    41. Metra M, Eichhorn E, Abraham WT, Linseman J, Böhm M, Corbalan R, DeMets D, De Marco T, Elkayam U, Gerber M, Komajda M, Liu P, Mareev V, Perrone SV, Poole-Wilson P, Roecker E, Stewart J, Swedberg K, Tendera M, Wiens B, Bristow MR. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. Eur Heart J. 2009 Dec; 30(24):3015-26. PMID: 19700774; PMCID: PMC2792716.
    42. Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ, McGlothlin D, Grossman W, De Marco T, Yeghiazarians Y. Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant. 2009 Oct; 28(10):1081-6. PMID: 19782291.
      View in: PubMed
    43. Jensen BC, Swigart PM, De Marco T, Hoopes C, Simpson PC. {alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium. Circ Heart Fail. 2009 Nov; 2(6):654-63. PMID: 19919991; PMCID: PMC2780440.
    44. Chen H, Shiboski SC, Golden JA, Gould MK, Hays SR, Hoopes CW, De Marco T. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009 Sep 01; 180(5):468-74. PMID: 19520906; PMCID: PMC2742763.
    45. Khush KK, Tasissa G, Butler J, McGlothlin D, De Marco T. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J. 2009 Jun; 157(6):1026-34. PMID: 19464413.
      View in: PubMed
    46. McManus D, De Marco T, 3rd Edition, McGraw-Hill/Lange.2009; 352-70.
    47. Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, Emerman CL. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology. 2009; 113(1):12-9. PMID: 18931492.
      View in: PubMed
    48. Boehmer JP, Carlson MD, De Marco T, Jaski BE, Higgins SL, Kennergren C, Epstein AE. Adjudication of mortality events in a heart failure-arrhythmia trial by a multiparameter descriptive method: comparison with methods used in heart failure trials and methods used in arrhythmia trials. J Interv Card Electrophysiol. 2008 Nov; 23(2):101-10. PMID: 18600437.
      View in: PubMed
    49. Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AH. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008 May 15; 358(20):2117-26. PMID: 18480204.
      View in: PubMed
    50. Chen H, De Marco T, Golden JA, Gould MK. Utility of CT for predicting pulmonary hypertension in patients with parenchymal lung disease: similar results, different conclusion? Chest. 2008 Apr; 133(4):1053-4; author reply 1054. PMID: 18398135.
      View in: PubMed
    51. Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, Grossman W, De Marco T, Yeghiazarians Y. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med. 2008 Jun 01; 177(11):1268-75. PMID: 18310479.
      View in: PubMed
    52. De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. J Card Fail. 2008 Feb; 14(1):9-18. PMID: 18226768.
      View in: PubMed
    53. Khush KK, Shah SJ, Ristow B, De Marco T, Whooley MA, Schiller NB. Association of African American race with elevated pulmonary artery diastolic pressure: data from the Heart and Soul Study. J Am Soc Echocardiogr. 2007 Nov; 20(11):1307-13. PMID: 17588717; PMCID: PMC2776673.
    54. Fix OK, Bass NM, De Marco T, Merriman RB. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol. Liver Transpl. 2007 Jun; 13(6):875-85. PMID: 17539008.
      View in: PubMed
    55. Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Pina IL, Fonarow GC, De Marco T, Pauly DF, Rogers J, DiSalvo TG, Butler J, Hare JM, Francis GS, Stough WG, O'Connor CM.Characterization and prognostic value of persistent hyponatreia in patients with severe heart failure in the ESCAPE trial. Arch Intern Med. 2007.
    56. McGlothlin D, De Marco T. 2007; 2(6):66-73.
    57. Elkayam U, Tasissa G, Binanay C, Wagoner L, Gheorghiade M, Warnica JW, Young J, Raybum BK, Rogers J, De Marco T, Leier CV.Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart Journal. 2007; (153):99-104.
    58. Ghali JK, Boehmer J, Feldman AM, Saxon LS, De Marco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR.J Card Fail. Influence of diabetes on cardiac resynchronizaiton therapy with or without defibrillator in patients with advanced heart failure. 2007; 9(13):769-73.
    59. Lindenfeld J, Fledman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, De Marco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M.Effects of cardiac resynchronization therapy with or without defibrillator on survival and hospitalization in patients with NYHA class IV heart failure. Circulation. 2007; 2(115):204-12.
    60. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 2006 Dec 19; 114(25):2766-72. PMID: 17159063.
      View in: PubMed
    61. De Marco T. Pulmonary arterial hypertension and women. Cardiol Rev. 2006 Nov-Dec; 14(6):312-8. PMID: 17053380.
      View in: PubMed
    62. Khush KK, De Marco T, Vakharia KT, Harmon C, Fineman JR, Chatterjee K, Michaels AD. Nesiritide acutely increases pulmonary and systemic levels of nitric oxide in patients with pulmonary hypertension. J Card Fail. 2006 Sep; 12(7):507-13. PMID: 16952783.
      View in: PubMed
    63. Galvao M, Kalman J, De Marco T, Fonarow GC, Galvin C, Ghali JK, Moskowitz RM and the ADHERE Scientific Advisory Committee, Investigators, Coordinators and Study Group.Gender Differences in In-Hospital Management and Outcomes in Patients with Decompensated Heart Failure: Analysis From the Acute Decompensated Heart Failure National Registry (ADHERE). J Cardiac Fail. 2006; 2(12):100-7.
    64. De Marco T. 2006; 6(14):312-8.
    65. Marcus GM, Rose E, Viloria EM, Schafer J, De Marco T, Saxon LA, Foster E. Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol. 2005 Dec 20; 46(12):2208-14. PMID: 16360048.
      View in: PubMed
    66. Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. J Am Coll Cardiol. 2005 Dec 20; 46(12):2311-21. PMID: 16360064.
      View in: PubMed
    67. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006 Jan 03; 47(1):76-84. PMID: 16386668.
      View in: PubMed
    68. Michaels AD, Chatterjee K, De Marco T. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension. J Card Fail. 2005 Aug; 11(6):425-31. PMID: 16105633.
      View in: PubMed
    69. Laney AS, De Marco T, Peters JS, Malloy M, Teehankee C, Moore PS, Chang Y. Kaposi sarcoma-associated herpesvirus and primary and secondary pulmonary hypertension. Chest. 2005 Mar; 127(3):762-7. PMID: 15764755.
      View in: PubMed
    70. Oka RK, De Marco T, Haskell WL. Effect of treadmill testing and exercise training on self-efficacy in patients with heart failure. Eur J Cardiovasc Nurs .2005; 3(4):215-9.
    71. 8. De Marco T, Rapaport E. Cor pulmonale. In Mason RJ, Broaddus VC, Murray JF, Nadel JA (eds): Murray and Nadel's Textbook of Respiratory Medicine, 4th edition. Philadelphia: Saunders.2005; 1544-70.
    72. Frost AE, Langleben D, Oudiz R, Hill N, Horn E, McLaughlin V, Robbins IM, Shapiro S, Tapson VF, Zwicke D, De Marco T, Schilz R, Rubenfire M, Barst RJ.The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Vascul Pharmacol. 2005; 1(43):36-9.
    73. De Marco T, McGlothlin D. Managing Right Ventricular Failure in PAH. Advances in Pulmonary Hypertension.2005; 4(4):16-26.
    74. O’Connell JW, Schreck C, Moles M, Badhwar N, De Marco T, Olgin J, Lee B, Tseng Z, Kumar U, Botvinick EH .A unique method by which to quantitate synchrony with equilibrium radionuclide angiography. J Nucl Cardiol. 2005; 4(12):215-50.
    75. Nath J, De Marco T, Hourigan L, Heidenreich PA, Foster E. .Correlation between right ventricular indices and clinical improvement in epoprostenol treated pulmonary hypertension patients. Echocardiography. 2005; 5(22):374-9.
    76. Mann MJ, Tseng E, Ratcliffe M, Strattman G, De Silva A, De Marco T, Achorn N, Moskalik W, Hoopes C. Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopenia. J Heart Lung Transplant .2005; 2(24):222-5.
    77. Horwich T, Foster E, De Marco T, Tseng Z, Saxon L. Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices. J Cardiovasc Electrophysiol. 2004 Nov; 15(11):1284-9. PMID: 15574179.
      View in: PubMed
    78. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004 May 20; 350(21):2140-50. PMID: 15152059.
      View in: PubMed
    79. Marcus GM, Michaels AD, De Marco T, McCulloch CE, Chatterjee K. Usefulness of the third heart sound in predicting an elevated level of B-type natriuretic peptide. Am J Cardiol. 2004 May 15; 93(10):1312-3. PMID: 15135714.
      View in: PubMed
    80. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003 Oct 15; 42(8):1454-9. PMID: 14563591.
      View in: PubMed
    81. Lee SJ, McCulloch C, Mangat I, Foster E, De Marco T, Saxon LA. Isolated bundle branch block and left ventricular dysfunction. J Card Fail. 2003 Apr; 9(2):87-92. PMID: 12751128.
      View in: PubMed
    82. Chatterjee K, De Marco T. Role of nonglycosidic inotropic agents: indications, ethics, and limitations. Med Clin North Am. 2003 Mar; 87(2):391-418. PMID: 12693731.
      View in: PubMed
    83. Choo DC, Huiskes B, Jones J, Fabbri S, Hawkins LA, Chatterjee K, De Marco T, Heywood JT. Amiodarone rescue therapy for severe decompensated heart failure initially unsuitable for beta-blockers. J Cardiovasc Pharmacol Ther 2003 Sep;8(3):187-92.2003; 3(8):187-92.
    84. Chatterjee K, De Marco T, Alpert JS. Pulmonary hypertension: hemodynamic diagnosis and management. Arch Intern Med. 2002 Sep 23; 162(17):1925-33. PMID: 12230414.
      View in: PubMed
    85. De Marco T. The MIRACLE trial has merit. J Card Fail. 2002 Aug; 8(4):204-5. PMID: 12397567.
      View in: PubMed
    86. Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation. 2002 Mar 19; 105(11):1304-10. PMID: 11901040.
      View in: PubMed
    87. Saxon LA, De Marco T. Arrhythmias associated with dilated cardiomyopathy. Card Electrophysiol Rev. 2002 Feb; 6(1-2):18-25. PMID: 11984010.
      View in: PubMed
    88. Soran O, Fleishman B, De Marco T, Grossman W, Schneider VM, Manzo K, de Lame PA, Feldman AM. Enhanced External Counterpulsation in Patients With Heart Failure: A Multicenter Feasibility Study. Congest Heart Fail .2002; 4(8):204-8.
    89. Missov E, De Marco T. 2000; (2):149-58.
    90. Schwitter J, De Marco T, Kneifel S, Von Schulthess M, Jorg C, Arheden H, Ruhm S, Stumpf K, Buck A, Parmley WW, Luscher TF, Higgins C. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography. Circulation.2000; 23(101):269-72.
    91. Nanevicz T, Piette J, Zipkin D, Serlin M, Ennis S, De Marco T, Modin G. The feasibility of a telecommunication service in support of outpatient congestive heart failure care in a diverse patient population. Congest Heart Fail .2000; (6):140-5.
    92. Missov E, De Marco T. 2000; (2):149-58.
    93. Kerwin WF, Botvinick EH, O’Connell JW, Merrick SH, De Marco T, Chatterjee K, Scheibly K, Saxon LA. Ventricular contraction abnormalities in dilated cardiomyopathy: Effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol .2000; 5(35):1221-7.
    94. Oka RK, De Marco T, Haskel WB, Botvinick E, Dae MW, Bolen K, Chatterjee K. Impact of a home-based walking and resistance training program on quality of life in patients with heart failure. Am J Cardiol .2000; 3(85):365-9.
    95. Zellner C, Protter AA, Ko E, Pothireddy R, De Marco T, Hutchison SJ, Chou TM, Chatterjee K, Sudhir K. Coronary vasodilator effects of BNP: Mechanisms of action in coronary conductance and resistance arteries. Am J Physiol .1999; 45(276):H1049-57.
    96. Missov E, De Marco T. 1999; (284):175-85.
    97. Schwitter J, De Marco T, Globits T, Sakuma H, Klinski C, Chatterjee K, Parmley WWP, Higgins CB. Influence of fenoldipine on left ventricular hypertrophy and systolic function in orthotopic heart transplant recipients: Possible interaction with cyclosporine medication. J Heart Lung Transplant.1999; (18):1003-13.
    98. Oka RK, De Marco T, Haskell WL. Perceptions of physical fitness in patients with heart failure. Progress in Cardiovasc Nursing.1999; 3(14):97-102.
    99. De Marco T, Chatterjee K. Phosphodiesterase inhibitors in refractory heart failure: Bridge to ß-blockade? J Am Coll Cardiol.1998; 6(31):1341-3.
    100. De Marco T, Parmley WW. ß-adrenergic blockers in the management of heart failure. Western J Med .1998; 6(168):531.
    101. Chatterjee K, De Marco T, Colucci WS, Massie BM, Chatterjee K, Coats AJS (eds): Heart Failure Scientific Principles and Clinical Practice. New York, NY, Churchill Livingstone Inc.1997; 853-73.
    102. Shinbane JS, Chu E, De Marco T, Sobol Y, Fitzpatrick AP, Lau DM, Klinski C, Schiller J, Griffin JC, Chatterjee KC. Evaluation of acute dual-chamber pacing with a range of atrioventricular delays on cardiac performance in refractory heart failure. J Am Coll Cardiol .1997; (30):1295-1300.
    103. De Marco T, Goldman L. Predicting outcomes in severe heart failure. Editorial. Circulation .1997; 12(95):2597-9.
    104. De Marco T, Chatterjee, K. Refractory heart failure: A therapeutic approach. J Intensive Care Med .1996; (11):121-48.
    105. Chou T, Sudhir K, Amidon T, Klinski C, De Marco T, Chatterjee K, Botvinick EH. Adenosine produces greater coronary hyperemic response in heart transplant recipients in comparison to dipyridamole. Am J Cardiol .1996; (78):908-13.
    106. Sudhir K, De Marco T, Kumar S, Maganti K, Amidon TM, de Groot CJ, Klinski C, Lau D, Keith F, Taylor RN, et al. Transcoronary and pulmonary vascular dynamics of endothelin-1 in cardiac transplant recipients. J Heart Lung Transplant .1995; 2(14):230-6.
    107. Chatterjee K, De Marco T, Beamish RE, Takeda N, Nagano M (eds): The Failing Heart. New York, NY, Raven Press, Ltd. .1995; 337-53.
    108. Barbant SD, Redberg RF, Tucker KJ, Chatterjee K, De Marco T, Foster E, Schiller NB. Abnormal pulmonary artery pressure profile after cardiac transplantation: An exercise Doppler echocardiographic study. Am Heart J.1995; 6(129):1185-92.
    109. Sudhir K, MacGregor JS, De Marco T, De Groot CJM, Taylor RN, Chou TM, Yock PG, Chatterjee K. Cyclosporin impairs release of endothelin derived relaxing factor in epicardial and resistance coronary arteries. Circulation .1994; 3018-23(90).
    110. De Marco T, Keith F. Bridge to Cardiac Transplantation In Parmley WW, Chatterjee K, (eds): Cardiology. Philadelphia JB Lippincott Publishing Co., .1994; 7(3):1-21.
    111. Chatterjee K, Wolfe CL, De Marco T. 1994.
    112. Cavero PG, Sudhir K, Galli F, De Marco T, Keith F, Chatterjee K. Effect of orthotopic cardiac transplantation on peripheral vascular function in congestive heart failure: Influence of cyclosporine therapy. Am Heart J .1994; 6(127):1581-7.
    113. Tucker K, Redberg R, Ploss D, De Marco T, Foster E, Schiller N. Noninvasive assessment of the pulmonary artery pressure response to exercise after uncomplicated heart transplantation. J Heart Lung Transplant 1993.1993; (12):604-12.
    114. Galli FC, Damon LE, Tomlanovich SJ, Keith F, Chatterjee K, De Marco T. 1993; (12):440-4.
    115. Bersin RM, Kwasman M, Lau D, Klinski C, Tanaka K, Khorrami P, De Marco T, Wolfe CL, Chatterjee K. Importance of oxygen-hemoglobin binding to oxygen transport in congestive heart failure. British Heart J .1993; (70):443-7.
    116. Truit LC, Denaro CP, Lake JR, De Marco T. 1991; (12):651-9.
    117. Sudhir K, Fitzgerald P, MacGregor JA, De Marco T, Chatterjee K, Yock P. Transvenous coronary ultrasound imaging: A novel approach to visualization of the coronary arteries. Circulation .1991; (84):1957-61.
    118. White M, Rouleau J-L, Ruddy TD, De Marco T, Moher D, Chatterjee K. Decreased coronary sinus oxygen content: A predictor of adverse prognosis in patients with severe heart failure. J Am Coll Cardiol .1991; (18):1631-7.
    119. Hosenpud JD, De Marco T, Frazier OH, Griffith BP, Menkins AH, O'Connell JB, Olivari MT, Valentine HA. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Circulation .1991; (supp III):338-43.
    120. Chatterjee K, De Marco T. 1990; 4(39):29-40.
    121. Stein MG, De Marco T, Gamsu G, Finkbeiner W, Golden JA. Computed tomography: Pathologic correlation in lung disease due to tocainide. Am Rev Respr Dis 1988; 137:458-60.1988; (137):458-60.
    122. Chatterjee K, De Marco T, Rouleau J-L. Vasodilator therapy in chronic congestive heart failure. Am J Cardiol 1988; 62:46A-54A.1988; (62):46A-54A.
    123. De Marco T, Daly PA, Liu M, Kayser S, Parmley WW, Chatterjee K. Enalaprilat: A new parental angiotensin-converting enzyme inhibitor: Rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure. J Am Coll Cardiol 1987; 9:1131-38.1987; (9):1131-8.
    124. De Marco T, Chatterjee K. A patient with fatigue and jugular venous distention. The Complicated Cardiovascular Patient.1987; 3(1):9-12.
    125. Axelrod RD, De Marco T, Dae M, Botvinick EH, Chatterjee K. Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure. J Am Coll Cardiol 1987; 9:1124-30.1987; (9):1124-30.
    126. De Marco T, Chatterjee K. A patient with refractory congestive heart failure. The Complicated Cardivascular Patient. 1987; 1(2):20-31.1987; 2(1):20-31.
    127. Hansen RM, Viquerat C, Wiener-Kronish JP, De Marco T, Bahtia S, Marks JD, Botvinick EH, Chatterjee K, Matthay. Poor correlation between pulmonary arterial wedge pressure and left ventricular end-diastolic volume after coronary artery bypass graft surgery. Anesthesiology 1986; 64(6):764-70.1986; 6(64):764-70.